Provided by Tiger Trade Technology Pte. Ltd.

Incyte

110.78
-2.6600-2.34%
Volume:687.61K
Turnover:76.50M
Market Cap:22.45B
PE:14.11
High:113.65
Open:112.89
Low:110.08
Close:113.44
52wk High:132.60
52wk Low:82.82
Shares:202.70M
Float Shares:169.82M
Volume Ratio:0.70
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.85
EPS(LYR):6.41
ROE:30.67%
ROA:16.83%
PB:3.54
PE(LYR):17.28

Loading ...

Incyte Schedules Second-quarter Results Conference Call and Webcast

Reuters
·
Jul 08

Incyte is Maintained at Sector Perform by RBC Capital

Dow Jones
·
Jul 07

RBC Capital Adjusts Incyte Price Target to $99 From $95, Maintains Sector Perform Rating

MT Newswires Live
·
Jul 07

Adagene Posts Investor Presentation Highlighting Adg126 Masked Anti-ctla-4 Program in MSS Colorectal Cancer

Reuters
·
Jul 07

Incyte Corp. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 07

Incyte Completes USD 1.25 Billion Acquisition of Vega Therapeutics

Reuters
·
Jul 06

Press Release: Incyte Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding Its Hematology Portfolio

Dow Jones
·
Jul 06

Uk's MHRA Approves Retifanlimab for Treatment of Advanced Merkel Cell Skin Cancer

Reuters
·
Jul 06

Incyte Corp. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 03

US FDA Approves Orca Bio's Blood Cancer Therapy

Reuters
·
Jul 01

Incyte Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Jul 01

Incyte Price Target Maintained with a $140.00/share by HC Wainwright & Co.

Dow Jones
·
Jun 29

Barclays Keeps Their Buy Rating on Incyte (INCY)

TIPRANKS
·
Jun 29

Weekly Winners | Bio-Techne Soars 23%; AbbVie Surges 17%; United Airlines Jumps 15%; Corning, Merck Gain 13%

Tiger Newspress
·
Jun 28

Accenture, Estée Lauder, Luckin, Incyte, BILL Trending

TIPRANKS
·
Jun 27

Incyte Corp. Stock Rises 5.8%, Outperforms Peers

Dow Jones
·
Jun 27

Incyte is Maintained at Neutral by UBS

Dow Jones
·
Jun 27

Incyte Winds Down Itacitinib Rollover Study: What Investors Should Know

TIPRANKS
·
Jun 27

Movement Alert|Incyte Rises 5.84% in Regular Trading, Opzelura Receives Positive EU CHMP Opinion for Atopic Dermatitis

Market Focus
·
Jun 27

Incyte Shares Rise 5.2% After Co Announces Positive EU Regulatory Opinion for Opzelura Skin Disease Treatment

THOMSON REUTERS
·
Jun 26